Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03417362
Other study ID # AC17102
Secondary ID 2354872018/00601
Status Completed
Phase N/A
First received
Last updated
Start date March 5, 2018
Est. completion date March 12, 2019

Study information

Verified date March 2019
Source NHS Lothian
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The majority of abortions in the United Kingdom (UK) are performed before 9 weeks (63 days) gestation using a method known as Early Medical Abortion (EMA). EMA involves an assessment visit and provision of two types of medication .

The assessment visit usually involves Ultrasound to confirm gestation, detailed personal history, safeguarding assessment and contraception planning, before arranging treatment and follow up.

The process is long and lots of information is given to women attending the service. In NHS Lothian (National Health Service, Lothian Health Board), the average appointment length for combined assessment and provision of the first part of treatment is 3 hours.

Despite how common abortion is ( 1 in 3), many women presenting for abortion care are not aware of what the procedure will involve. This may in part to the social stigma surrounding abortion and unintended pregnancy in general. This stigma can in turn result in feelings of anxiety and shame about the decision to terminate a pregnancy.

There is evidence that short videos shown to patients prior to abortion or contraception consultations can improve their ability to recall information and can make them feel more confident about the procedure.

Additionally, abortion care providers have found patients who have seen videos to be better prepared and informed and this allows consultations to progress more easily and allow greater time for discussion of contraceptive methods.

We have prepared a video approximately 3 minutes in length to provide information about EMA. It summarises the process described above using simple language and animated characters. The video has been translated into French, Portuguese and Swedish and has been adapted to reflect subtle differences in practice and law in these countries. We have partners in services in these three countries who will be conducting the trial there in accordance with this protocol and their own local ethics and clinical governance requirements.


Description:

Despite abortion being a common medical procedure, many women do not have access to good quality, reliable information about it. This may stem from the stigma and shame surrounding the procedure leading to less community knowledge and experience sharing compared to other medical conditions, for example diabetes or heart disease.

Lack of knowledge and understanding about a medical procedure can cause anxiety, distress and confusion when seeing a healthcare professional, which in turn can prolong consultations.

By introducing the short video animation, we are hoping that this will give the women attending the service a basic level of knowledge about Early Medical Abortion, reduce the anxiety and worry they are experiencing by informing them, and make them feel more confident and clear during their consultations.

It has been shown in other studies that short videos in contraception and abortion consultations can have this impact, but a randomised control trial methodology has never been applied to this intervention.

In a standard initial Early Medical Abortion visit a patient will experience the following Patient Journey:

1. Arrival and registration

2. Waiting for appointment in waiting room

3. Ultrasound scan to determine gestation

4. Self taken vulvovaginal swab for Chlamydia and Gonorrhoea screening

5. Blood tests for : HIV, Syphilis, Full Blood Count, Blood Group

6. Return to the waiting room

7. Assessment consultation with healthcare professional (i.e. Specialist Nurse or Doctor)

8. Return to the waiting room

9. Treatment Consultation: to receive 'first part' of treatment i.e. Mifepristone and dates for 'second part' 24-48 hours later.

10. Leave department

In the study, the above will happen, however patients will be given a participant information sheet (at step 1 above )when they arrive in department to register. At Step 6, when the patient has returned to the waiting room, eligible patients will be approached and asked if they would like to participate and if so will be randomised to 'standard of care' or 'intervention' (i.e. the video). They will resume the Patient Journey above and will again be approached at Step 8 or Step 10 to complete the short questionnaire.

For the questionnaire: a single researcher will record, on a standard proforma, what information the subject had taken from the consultation and its accuracy, and the overall acceptability of the consultation using a Likert scale to quantify descriptors such as 'helpful', 'informative', 'understandable', 'impersonal', 'sympathetic' 'unsympathetic' etc.

The number of women declining to participate in the study would be recorded .


Recruitment information / eligibility

Status Completed
Enrollment 174
Est. completion date March 12, 2019
Est. primary completion date March 12, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 16 Years and older
Eligibility Inclusion Criteria:

1. Female

2. Pregnant

3. Presenting for Termination of Pregnancy

4. Aged 16 years or over

5. Able to understand English (the video is in English, and whilst translations are available, their content has been altered to reflect abortion laws in other countries)

6. Gestation of 9 weeks (63 days) or less on ultrasound scan

7. Able to provide consent

Exclusion Criteria:

1. Non pregnant

2. Pregnancy of Unknown Location

3. Uncertain of decision or wishing to continue pregnancy

4. 15 years old or younger

5. Unable to understand English

6. Gestation 9 weeks and 1 day (64 days) or greater on ultrasound scan.

7. Unable to provide consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Animation
3 minute video describing and explaining early medical abortion, followed by questionnaire

Locations

Country Name City State
France Assistance Publique Hopitaux de Paris Paris
Sweden Karolinska University Hospital Stockholm
United Kingdom Chalmers Centre for Sexual and Reproductive Health Edinburgh

Sponsors (1)

Lead Sponsor Collaborator
NHS Lothian

Countries where clinical trial is conducted

France,  Sweden,  United Kingdom, 

References & Publications (2)

Michie L, Cameron ST, Glasier A, Johnstone A. Giving information about the contraceptive implant using a DVD: is it acceptable and informative? A pilot randomised study. J Fam Plann Reprod Health Care. 2016 Jul;42(3):194-200. doi: 10.1136/jfprhc-2015-101186. Epub 2015 Aug 6. — View Citation

Powell-Jackson R, Glasier A, Cameron ST. Benefits of using a digital video disk for providing information about abortion to women requesting termination of pregnancy. Contraception. 2010 Jun;81(6):537-41. doi: 10.1016/j.contraception.2010.01.015. Epub 2010 Feb 19. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Is the recall of key information about EMA similar after watching the video compared to following face to face contact with a clinician? The patient will be asked to recall any facts that they learned from watching the video/from the consultation and this will be compared to a list held by the researcher. A numerical score for points recalled will be generated for each patient. Immediately during questionnaire
Secondary What place/ role do women who watch the video feel that it has (if any)? Open ended questions in the questionnaire to ask participants their thoughts on video and when/where it could be viewed in relation to their treatment. The participant can select an answer from a list of options or volunteer their own. Immediately during questionnaire
Secondary Do women find it acceptable to receive information about Early Medical Abortion (EMA) via an animated video? Likert Scale completed with researcher around a series of different statements relating to their acceptability of the video. Positive responses will be grouped and an overall result of 'acceptable' or 'not acceptable' will be assigned per case. Immediately during questionnaire
See also
  Status Clinical Trial Phase
Terminated NCT04056637 - Choice of Modality of Follow up for Medication Abortion N/A
Active, not recruiting NCT05896657 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 N/A
Active, not recruiting NCT03736681 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage Phase 1
Completed NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o Phase 3
Completed NCT04446572 - Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin Phase 2
Not yet recruiting NCT03267771 - Progesterone and Doppler in Recurrent Abortion Phase 4
Recruiting NCT05341817 - The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy Phase 4
Completed NCT03079622 - Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks N/A
Recruiting NCT05182008 - A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial N/A
Completed NCT03896022 - Auriculotherapy - Pain Management of Aspiration Abortion N/A
Completed NCT03925129 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation N/A
Suspended NCT03751423 - Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion Phase 3
Completed NCT03480009 - Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion Phase 3
Completed NCT05469594 - Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Completed NCT05320432 - Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion N/A
Completed NCT03187002 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion N/A
Terminated NCT04139382 - Using Telemedicine to Improve Early Medical Abortion at Home N/A
Recruiting NCT04956731 - Pharmacist Provision of Medication Abortion N/A
Recruiting NCT04336358 - Telemedicine for First Trimester Abortion in South Africa N/A
Completed NCT02096575 - Nitrous Oxide for Pain Management of First Trimester Surgical Abortion N/A